MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.gastro.2025.10.005

Медицинская библиотека · Gastroenterology · 2025

Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease.

Torp Nikolaj, Johansen Stine, Jensen Ellen Lyngbeck, Maagaard Markus, Semmler Georg, Andersen Mette Lehmann, Bech Katrine, Schnefeld Helle, Lindvig Katrine Prier, Thorhauge Katrine Holtz, Petersen Ellen Elise, Hansen Johanne Kragh, Villesen Ida Falk, Andersen Peter, Bergmann Marianne Lerbæk, Leeming Diana Julie, Karsdal Morten, Hansen Camilla Dalby, Thiele Maja, Israelsen Mads, Krag Aleksander

СтатьяПеревод в очереди

Аннотация

BACKGROUND & AIMS: Alcohol is a key driver of liver-related mortality, and phosphatidylethanol (PEth) is a direct biomarker of alcohol intake. We investigated the prognostic performance of PEth with noninvasive liver fibrosis tests (NITs) for predicting hepatic decompensation in an alcohol-related liver disease (ALD) at-risk population.

METHODS

Prospective cohort study with 411 at risk of ALD without prior known chronic liver disease of whom 162 had a follow-up PEth. PEth was measured from whole blood by liquid chromatography-mass spectrometry. PEth, self-reported alcohol intake, and 3 NITs: enhanced liver fibrosis (ELF) test, an algorithm incorporating PRO-C3 (ADAPT), and transient elastography (TE) were assessed at baseline. By review of medical records, participants were followed for up to 5 years for hepatic decompensation.

RESULTS

Baseline PEth was 338 ng/mL (interquartile range [IQR]: 32-921 ng/mL) and median time to follow-up PEth was 26 months (IQR: 17-33). Baseline PEth was associated with decompensation (subdistribution hazard ratio [sHR] per 100 ng/mL, 1.04; 95% confidence interval [CI], 1.01-1.06), independently of NITs. Liver fibrosis NITs were the strongest individual predictors, but PEth added incremental 6-month prognostic value. Discriminatory accuracy of PEth declined with an area under the curve of 0.77 at 6 months to 0.62 at 2 years, whereas fibrosis-based NITs maintained an area under the curve of ∼0.90. Of those with a follow-up PEth, 79 (49%) had increased PEth levels compared with baseline, and 83 (51%) had stable or lowered PEth. An increased follow-up PEth was significantly associated with a higher risk of subsequent hepatic decompensation (sHR, 4.92; 95% CI, 1.09-22.34; P = .039).

CONCLUSIONS

PEth predicts hepatic decompensation independently of fibrosis-based NITs in individuals at risk of ALD. Although its prognostic performance declines rapidly, repeated PEth measurements maintain prognostic discrimination.

Для цитирования: Torp Nikolaj, Johansen Stine, Jensen Ellen Lyngbeck, Maagaard Markus, Semmler Georg, Andersen Mette Lehmann, Bech Katrine, Schnefeld Helle, Lindvig Katrine Prier, Thorhauge Katrine Holtz, Petersen Ellen Elise, Hansen Johanne Kragh, Villesen Ida Falk, Andersen Peter, Bergmann Marianne Lerbæk, Leeming Diana Julie, Karsdal Morten, Hansen Camilla Dalby, Thiele Maja, Israelsen Mads, Krag Aleksander. Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease.. Gastroenterology. 2025. DOI: 10.1053/j.gastro.2025.10.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.